These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25103845)

  • 1. T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.
    Blachère NE; Orange DE; Santomasso BD; Doerner J; Foo PK; Herre M; Fak J; Monette S; Gantman EC; Frank MO; Darnell RB
    Eur J Immunol; 2014 Nov; 44(11):3240-51. PubMed ID: 25103845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease.
    Steinman L
    Eur J Immunol; 2014 Nov; 44(11):3201-5. PubMed ID: 25319369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
    Eck SC; Turka LA
    Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.
    Yshii LM; Gebauer CM; Pignolet B; Mauré E; Quériault C; Pierau M; Saito H; Suzuki N; Brunner-Weinzierl M; Bauer J; Liblau R
    Brain; 2016 Nov; 139(11):2923-2934. PubMed ID: 27604307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system.
    Melzer N; Meuth SG; Wiendl H
    J Neurol; 2013 May; 260(5):1215-33. PubMed ID: 22983427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
    Snook AE; Magee MS; Schulz S; Waldman SA
    Eur J Immunol; 2014 Jul; 44(7):1956-66. PubMed ID: 24771148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of antigen-specific CD8+ CTL in MHC class I-deficient mice through CD4 to CD8 conversion.
    Tanaka Y; Koido S; Xia J; Ohana M; Liu C; Cote GM; Sawyer DB; Calderwood S; Gong J
    J Immunol; 2004 Jun; 172(12):7848-58. PubMed ID: 15187169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity.
    Herz J; Paterka M; Niesner RA; Brandt AU; Siffrin V; Leuenberger T; Birkenstock J; Mossakowski A; Glumm R; Zipp F; Radbruch H
    J Neuroinflammation; 2011 Oct; 8():131. PubMed ID: 21978405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
    von Kutzleben S; Pryce G; Giovannoni G; Baker D
    Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.
    Sasaki K; Bean A; Shah S; Schutten E; Huseby PG; Peters B; Shen ZT; Vanguri V; Liggitt D; Huseby ES
    J Immunol; 2014 Apr; 192(7):3029-42. PubMed ID: 24591371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity.
    Magnusson FC; Liblau RS; von Boehmer H; Pittet MJ; Lee JW; Turley SJ; Khazaie K
    Gastroenterology; 2008 Apr; 134(4):1028-37. PubMed ID: 18395084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60.
    Ryu SJ; Jung KM; Yoo HS; Kim TW; Kim S; Chang J; Choi EY
    Blood; 2009 Apr; 113(18):4273-80. PubMed ID: 19139082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen.
    Surman DR; Dudley ME; Overwijk WW; Restifo NP
    J Immunol; 2000 Jan; 164(2):562-5. PubMed ID: 10623795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions.
    Le Saout C; Mennechet S; Taylor N; Hernandez J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19414-9. PubMed ID: 19033460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses in the central nervous system.
    Korn T; Kallies A
    Nat Rev Immunol; 2017 Mar; 17(3):179-194. PubMed ID: 28138136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
    J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.